650 related articles for article (PubMed ID: 15073680)
21. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.
Shafren DR; Williams DT; Barry RD
J Virol; 1997 Dec; 71(12):9844-8. PubMed ID: 9371658
[TBL] [Abstract][Full Text] [Related]
22. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.
Henke A; Zell R; Ehrlich G; Stelzner A
J Virol; 2001 Sep; 75(17):8187-94. PubMed ID: 11483764
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of coxsackievirus infection in cardiomyocytes by small dsRNA targeting its cognate coxsackievirus adenovirus receptor.
Sharma M; Mishra B; Saikia UN; Bahl A; Ratho RK
Indian J Med Res; 2017 Oct; 146(4):520-527. PubMed ID: 29434067
[TBL] [Abstract][Full Text] [Related]
24. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection.
Slifka MK; Pagarigan R; Mena I; Feuer R; Whitton JL
J Virol; 2001 Mar; 75(5):2377-87. PubMed ID: 11160741
[TBL] [Abstract][Full Text] [Related]
25. Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes.
Jarasch-Althof N; Wiesener N; Schmidtke M; Wutzler P; Henke A
Viral Immunol; 2010 Aug; 23(4):369-76. PubMed ID: 20712481
[TBL] [Abstract][Full Text] [Related]
26. Interspecies differences in virus uptake versus cardiac function of the coxsackievirus and adenovirus receptor.
Freiberg F; Sauter M; Pinkert S; Govindarajan T; Kaldrack J; Thakkar M; Fechner H; Klingel K; Gotthardt M
J Virol; 2014 Jul; 88(13):7345-56. PubMed ID: 24741103
[TBL] [Abstract][Full Text] [Related]
27. Single-Point Mutations within the Coxsackie B Virus Receptor-Binding Site Promote Resistance against Soluble Virus Receptor Traps.
Pinkert S; Kopp A; Brückner V; Fechner H; Beling A
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669334
[TBL] [Abstract][Full Text] [Related]
28. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
29. Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis.
Huber S; Song WC; Sartini D
Viral Immunol; 2006; 19(2):156-66. PubMed ID: 16817758
[TBL] [Abstract][Full Text] [Related]
30. Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis.
Ruppert V; Meyer T; Pankuweit S; Jonsdottir T; Maisch B
Cardiovasc Pathol; 2008; 17(2):81-92. PubMed ID: 18329552
[TBL] [Abstract][Full Text] [Related]
31. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.
Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U
J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888
[TBL] [Abstract][Full Text] [Related]
32. Attenuated strain of CVB3 with a mutation in the CAR-interacting region protects against both myocarditis and pancreatitis.
Lasrado N; Gangaplara A; Massilamany C; Arumugam R; Shelbourn A; Rasquinha MT; Basavalingappa RH; Delhon G; Xiang SH; Pattnaik AK; Steffen D; Reddy J
Sci Rep; 2021 Jun; 11(1):12432. PubMed ID: 34127684
[TBL] [Abstract][Full Text] [Related]
33.
Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
[TBL] [Abstract][Full Text] [Related]
34. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
[TBL] [Abstract][Full Text] [Related]
35. Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis.
Miteva K; Haag M; Peng J; Savvatis K; Becher PM; Seifert M; Warstat K; Westermann D; Ringe J; Sittinger M; Schultheiss HP; Tschöpe C; Van Linthout S
PLoS One; 2011; 6(12):e28513. PubMed ID: 22174827
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
[TBL] [Abstract][Full Text] [Related]
37. Macrophage-Specific Coxsackievirus and Adenovirus Receptor Deletion Enhances Macrophage M1 Polarity in CVB3-Induced Myocarditis.
Shin HH; Jeon ES; Lim BK
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982385
[TBL] [Abstract][Full Text] [Related]
38. Coxsackievirus B3 induction of NFAT: requirement for myocarditis susceptibility.
Huber SA; Rincon M
Virology; 2008 Nov; 381(2):155-60. PubMed ID: 18829062
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells.
Zhu H; Lou C; Liu P
Virol J; 2015 Nov; 12():189. PubMed ID: 26578236
[TBL] [Abstract][Full Text] [Related]
40. Virus-Host Interactions of Enteroviruses and Parvovirus B19 in Myocarditis.
Ho HT; Peischard S; Strutz-Seebohm N; Seebohm G
Cell Physiol Biochem; 2021 Nov; 55(6):679-703. PubMed ID: 34791861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
